| [1] |
Vaisbuch E, Romero R, Mazak-iTovi S, et al. Retinol binding protein 4－a novel association with early－onset preeclampsia[J]. J Perinat Med, 2010, 38:129-139.
|
| [2] |
Ma RQ, Sun MN, Yang Z. Effects of preeclampsia－like symptoms at early gestational stage on feto－placental outcomes in a mouse model[J]. Chin Med J (Eng), 2010, 123:707-712.
|
| [3] |
Yang Z, Wang JL, Huang P, et al. Study on unparalleled damage of end organs in severe preeclampsia and perinatal outcomes[J]. Chin J Perinat Med, 2006, 91:10-14.
|
| [4] |
Jenkins SM, Head BB, Hauth JC. Severe preeclampsia at <25 weeks of gestation: Maternal and neonatal outcomes[J]. Am J Obstet Gynecol, 2002, 186(4):790-795.
|
| [5] |
Hall DR, Odendaal HJ, Steyn DW, et al. Expectant management of early onset severe preeclampsia: Maternal outcome[J]. BJOG, 2000, 107(10):1252-1257.
|
| [6] |
Chesley L, Copper DW. Genetics of hypertension in pregnancy: Possible single gene control of pre－eclampsia and eclampsia in the descendants of eclamptic women[J]. Br J Obstet Gynecol, 1986, 93:898-908.
|
| [7] |
Esplin MS, Fausett MB, Fraser A, et al. Paternal and maternal components of the predisposition to pre－eclampsia[J]. N Engl J Med, 2001, 344:867-876.
|
| [8] |
Haddad T. Update on pre－eclampsia[J]. Int Anesthesiol Clin, 2002, 40:115-135.
|
| [9] |
Junus K, Centlow M, Wikstrom AK, et al. Gene expression profiling of placentae from women with early－ and late－onset pre－eclampsia: Down－regulation of the angiogenesis－related genes ACVRL1 and EGFL7 in early－onset disease[J]. Mol Hum Reprod, 2012, 18(3):146-155.
|
| [10] |
Lee T, Sumpio BE. Cell signalling in vascular cells exposed to cyclic strain: The emerging role of protein phosphatases[J]. Biotechnol Applochen, 2004, 39(pt2):129-139.
|
| [11] |
Aubard Y, Darodes N, Cantaloube M. Hyperhomocysteinemia and pregnancy review of our present understanding and therapeutic implications[J]. Eur J Obstet Gynecol Reprod Biol, 2000, 93(2):157-158.
|
| [12] |
Kanayama N. Trophoblastic injury: New etiological and pathological concept of preeclampsia[J]. Croat Med J, 2003, 44(2):148-156.
|
| [13] |
Chafet Z, Kuhnreich I, Sammar M, et al. First－trimester placental protein 13 screening for preeclampsia and intrauterine grow threstriction[J]. Am J Obstet Gynecol, 2007, 197(1):35, e1-7.
|
| [14] |
Sekizawa A, Sekizawa A, Purwosunu Y, et al. PP13 mRNA expression intropho－blasts from preeclamptic placentas[J]. Reprod Sci, 2009, 16(4):408-413.
|
| [15] |
Knox PG, Milner AE, Green NG, et al. Inhibition of metalloprotenase cleavage enhances the cytotoxicity of Fas Ligand[J]. J Immunol, 2003, 170(2):677-685.
|
| [16] |
Jongbloet PH. Offspring sex ratio at population level versus early and late onset preeclampsia[J]. Early Hum Dev, 2004, 79(2):159-163.
|
| [17] |
Shenhav S, Gemer O, Sassoon E, et al. Mid－trimester tripletest levels in early and late onset severe pre－eclampsia[J]. Prenat Diagn, 2002, 22(7):579-582.
|
| [18] |
Qi HB. Prediction of preeclampsia[J]. Chin J Obstet Gynecol Pediatr: Electron Ed, 2011, 7(3):194-196.
|
| [19] |
Nanjundan P, Bagga R, Kalra JK, et al. Risk factors for early onset severe pre－eclampsia and eclampsia among north Indian women[J]. Obstet Gynaecol, 2011, 31(5):384-389.
|
| [20] |
Cruz-Martinez R, Figueras F. The role of Doppler and placental screening[J]. Best Pract Res Clin Obstet Gynaecol, 2009, 23(6):845-855.
|
| [21] |
Baumann MU, Bersinger NA, Mohaupt MG, et al. First－trimester serum levels of soluble endoglin and soluble fms－like tyrosine kinase－1 as first－trimester markers for late－onset preeclampsia[J]. Am J Obstet Gynecol, 2008, 199(3):266. e1-6.
|
| [22] |
Kusanovic JP, Romero R, Chaiworapongsa T, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti－angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia[J]. J Matern Fetal Neonatal Med, 2009, 22(11):1021-1038.
|
| [23] |
Masoura S, Kalogiannidis IA, Gitas G, et al. Biomarkers in pre－eclampsia: A novel approach to early detection of the disease[J]. J Obstet Gynaecol, 2012, 32(7):609-616.
|
| [24] |
Vandenberghe G, Mensink I, Twisk JW, et al. First trimester screening for intra－uterine growth restriction and early－onset pre－eclampsia[J]. Prenat Diagn, 2011, 31(10):955-961.
|
| [25] |
Chafetz I, Kuhnreich I, Sammar M, et al. First－trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction[J]. Am J Obstet Gynecol, 2007, 197(1):35. e1-7.
|
| [26] |
Romero R, Kusanovic JP, Than NG, et al. First－trimester maternal serum PP13 in the risk assessment for preeclampsia[J]. Am J Obstet Gynecol, 2008, 199(2):122.e1-122.e11.
|
| [27] |
Akolekar R, Syngelaki A, Beta J, et al. Maternal serum placental protein 13 at 11－ 13 weeks of gestation in preeclampsia[J]. Prenat Diagn, 2009, 29(12):1103-1108.
|
| [28] |
Cowans NJ, Spencer K, Meiri H. First－trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes[J]. Prenat Diagn, 2008, 28(2):121-125.
|